Reactivation of Chronic Toxoplasmosis

慢性弓形虫病的重新激活

基本信息

  • 批准号:
    10239417
  • 负责人:
  • 金额:
    $ 24.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-02-01 至 2023-01-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Toxoplasma gondii is a widespread parasite of animals that cycles between cats, which shed infectious oocysts in their feces, and a variety of animals that harbor long-lived chronic infections. Humans are also commonly infected either by ingestion of oocysts in contaminated water, or by ingestion of tissue cysts in undercooked meat. Following infection, the parasite initially proliferates as fast-growing tachyzoites, which disseminate widely in the body. It then differentiates into semi-dormant bradyzoites that reside within tissue cysts, most commonly in muscle and brain. Although infections in healthy individuals are controlled by the immune system, tissue cysts persist in the face of immunity and are not eliminated by drug treatment. As such, chronic infections with T gondii pose a serious risk to HIV-infected AIDS patients due release of parasites from semi-dormant tissue cysts and re-emergence of the highly proliferative tachyzoite stage, which can lead to life threatening complications. Although once considered latent, newer studies reveal that bradyzoites replicate, albeit asynchronously and infrequently. Moreover, tissue cysts periodically rupture to release bradyzoites that infect new host cells and give rise to daughter tissue cysts. One barrier to egress of bradyzoites is their rigid cyst wall, comprised of proteins and carbohydrates, including the dominant antigen CST1, which is heavily glycosylated by O-linked sugars. Loss of CST1, or deletion of its mucin domain, results in fragile cysts, implying that this glycoprotein provides rigidity to the cell wall. Consistent with the idea that carbohydrates form a critical part of the cyst wall, our studies demonstrate that exogenously added glucanase and chitinase enzymes digest the cyst wall and result in release of bradyzoites. To explore endogenous pathways that control this process, we will examine the roles of two parasite glycosyl hydrolases that are expressed in bradyzoites, secreted from the parasite, and localized to the cyst wall. Genetic disruption of glucanase (GLN1) and chitinase-like protein (CLP1) genes in a cystogenic strain of T. gondii results in reduced formation of daughter cysts, supporting the hypothesis that these enzymes contribute to cyst maturation and turnover. We will examine the substrate specificity of these enzymes in vitro and assess their roles in vivo in formation and turnover of tissue cysts. We will also examine the role of these glycosyl hydrolases in chronic infection of immunocompromised mouse models that closely mimic impaired immunity seen in HIV-infected AIDS patients. The proposed studies will explore the hypothesis that glycosyl hydrolase enzymes contribute to the turnover of tissue cysts resulting in reactivation of toxoplasmosis, which poses a major risk for severe disease in HIV-infected AIDS patients.
项目总结/摘要 弓形虫是一种广泛存在于动物体内的寄生虫,在猫与猫之间循环, 粪便中的卵囊,以及各种长期慢性感染的动物。人类也是 通常通过摄入受污染的水中的卵囊或通过摄入 未煮熟的肉感染后,寄生虫最初增殖为快速生长的速殖子, 在体内广泛传播。然后分化为半休眠的缓殖子, 囊肿,最常见于肌肉和大脑。尽管健康个体的感染受到 在免疫系统中,组织囊肿在免疫力面前持续存在,并且不能通过药物治疗消除。因此,在本发明中, 慢性弓形虫感染对HIV感染的艾滋病患者构成严重风险, 半休眠的组织囊肿和高度增殖的速殖子阶段的重新出现,这可能导致生命 危险的并发症 虽然曾经被认为是潜伏的,但新的研究表明,缓殖子复制,尽管是异步的 而且很少。而且,组织包囊周期性破裂释放出感染新宿主细胞的缓殖子 并产生子组织囊肿。阻碍缓殖子排出的一个障碍是它们坚硬的囊壁, 蛋白质和碳水化合物,包括优势抗原CST 1,其通过O-连接的 糖。CST 1的缺失,或其粘蛋白结构域的缺失,导致脆弱的包囊,这意味着这种糖蛋白 为细胞壁提供刚性。与碳水化合物形成囊壁的关键部分的想法一致, 我们的研究表明,外源加入的葡聚糖酶和几丁质酶消化了孢囊壁, 导致缓殖子的释放。为了探索控制这一过程的内源性途径,我们将研究 两种寄生虫糖基水解酶的作用,其在缓殖子中表达,从寄生虫分泌,和 局限于囊壁一株大肠杆菌中葡聚糖酶(GLN 1)和几丁质酶样蛋白(CLP 1)基因的遗传破坏 T.弓形虫导致子包囊的形成减少,支持以下假设: 这些酶有助于包囊成熟和更新。我们将研究这些底物的特异性, 酶在体外和评估其在体内的作用,在形成和组织囊肿的周转。我们亦会研究 这些糖基水解酶在免疫受损小鼠模型慢性感染中的作用, 与艾滋病患者免疫力受损相似。拟议的研究将探讨这一假设 糖基水解酶有助于组织囊肿的周转,导致 弓形虫病,这是艾滋病毒感染的艾滋病患者严重疾病的主要风险。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

L. David Sibley其他文献

ワークショップ 本邦におけるトキソプラズマ分離株の分子タイピング
日本弓形虫分离株的分子分型研讨会
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    永宗喜三郎;喜屋武向子;山本徳栄;山野安規徳;Asis Khan;L. David Sibley
  • 通讯作者:
    L. David Sibley
Protozoan persister-like cells and drug treatment failure
原生动物类持久性细胞与药物治疗失败
  • DOI:
    10.1038/s41579-019-0238-x
  • 发表时间:
    2019-08-23
  • 期刊:
  • 影响因子:
    103.300
  • 作者:
    Michael P. Barrett;Dennis E. Kyle;L. David Sibley;Joshua B. Radke;Rick L. Tarleton
  • 通讯作者:
    Rick L. Tarleton
A combination of four emToxoplasma gondii/em nuclear-targeted effectors protects against interferon gamma-driven human host cell death
四种针对弓形虫核的效应蛋白的组合可防止干扰素γ驱动的人类宿主细胞死亡
  • DOI:
    10.1128/mbio.02124-24
  • 发表时间:
    2024-08-30
  • 期刊:
  • 影响因子:
    4.700
  • 作者:
    Brittany Henry;Aubrey J. Phillips;L. David Sibley;Alex Rosenberg
  • 通讯作者:
    Alex Rosenberg
Cerebral Malaria Is Regulated by Host-Mediated Changes in emPlasmodium/em Gene Expression
脑型疟疾受宿主介导的疟原虫基因表达变化调节
  • DOI:
    10.1128/mbio.03391-22
  • 发表时间:
    2023-04-10
  • 期刊:
  • 影响因子:
    4.700
  • 作者:
    Clare K. Cimperman;Mirna Pena;Sohret M. Gokcek;Brandon P. Theall;Meha V. Patel;Anisha Sharma;ChenFeng Qi;Daniel Sturdevant;Louis H. Miller;Patrick L. Collins;Susan K. Pierce;Munir Akkaya;L. David Sibley
  • 通讯作者:
    L. David Sibley
No more free lunch
天下没有免费的午餐
  • DOI:
    10.1038/415843a
  • 发表时间:
    2002-02-21
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    L. David Sibley
  • 通讯作者:
    L. David Sibley

L. David Sibley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('L. David Sibley', 18)}}的其他基金

Cryptosporidiosis and Oral Tolerance
隐孢子虫病和口服耐受
  • 批准号:
    10741600
  • 财政年份:
    2023
  • 资助金额:
    $ 24.82万
  • 项目类别:
Regulation of host cell egress by Toxoplasma gondii
弓形虫对宿主细胞出口的调节
  • 批准号:
    10640220
  • 财政年份:
    2022
  • 资助金额:
    $ 24.82万
  • 项目类别:
Regulation of host cell egress by Toxoplasma gondii
弓形虫对宿主细胞出口的调节
  • 批准号:
    10441782
  • 财政年份:
    2022
  • 资助金额:
    $ 24.82万
  • 项目类别:
Interferon-mediated control mechanisms in human cells
人类细胞中干扰素介导的控制机制
  • 批准号:
    10041166
  • 财政年份:
    2020
  • 资助金额:
    $ 24.82万
  • 项目类别:
Interferon-mediated control mechanisms in human cells
人类细胞中干扰素介导的控制机制
  • 批准号:
    10194376
  • 财政年份:
    2020
  • 资助金额:
    $ 24.82万
  • 项目类别:
Effect of Microbial Metabolites on Growth of Cryptosporidium
微生物代谢产物对隐孢子虫生长的影响
  • 批准号:
    9927337
  • 财政年份:
    2019
  • 资助金额:
    $ 24.82万
  • 项目类别:
Effect of Microbial Metabolites on Growth of Cryptosporidium
微生物代谢产物对隐孢子虫生长的影响
  • 批准号:
    10303025
  • 财政年份:
    2019
  • 资助金额:
    $ 24.82万
  • 项目类别:
Effect of Microbial Metabolites on Growth of Cryptosporidium
微生物代谢产物对隐孢子虫生长的影响
  • 批准号:
    10527363
  • 财政年份:
    2019
  • 资助金额:
    $ 24.82万
  • 项目类别:
INHIBITION OF STAT TRANSCRIPTION BY TOXOPLASMA
弓形虫对 STAT 转录的抑制
  • 批准号:
    9244190
  • 财政年份:
    2016
  • 资助金额:
    $ 24.82万
  • 项目类别:
Molecular Basis of Human Toxoplasmosis
人类弓形虫病的分子基础
  • 批准号:
    10557864
  • 财政年份:
    2015
  • 资助金额:
    $ 24.82万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 24.82万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.82万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 24.82万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.82万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 24.82万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 24.82万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.82万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 24.82万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 24.82万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.82万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了